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Abstract
Introduction
The disease burden and risk factors for respiratory syncytial virus (RSV) and human metap-
neumovirus (MPV) infections among children living in remote, rural areas remain unclear.
Materials and Methods
We conducted a prospective, household-based cohort study of children aged <3 years liv-
ing in remote rural highland communities in San Marcos, Cajamarca, Peru. Acute respira-
tory illnesses (ARI), including lower respiratory tract infection (LRTI), were monitored
through weekly household visits from March 2009 through September 2011. Nasal swabs
collected during ARI/LRTI were tested for RSV, MPV, and other respiratory viruses using
real-time RT-PCR. Incidence rates and rate ratios were calculated using mixed effects Pois-
son regression.
Results
Among 892 enrolled children, incidence rates of RSV and MPV ARI were 30 and 17
episodes per 100 child-years, respectively. The proportions of RSV and MPV ARI that pre-
sented as LRTI were 12.5% and 8.9%, respectively. Clinic visits for ARI and hospitalizations
were significantly more frequent (all p values <0.05) among children with RSV (clinic 41%
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and hospital 5.3%) and MPV ARI (38% and 3.5%) when compared with other viral infections
(23% and 0.7%) and infections without virus detected (24% and 0.6%). In multivariable
analysis, risk factors for RSV detection included younger age (RR 1.02, 95% CI: 1.00-1.03),
the presence of a smoker in the house (RR 1.63, 95% CI: 1.12-2.38), residing at higher alti-
tudes (RR 1.93, 95% CI: 1.25-3.00 for 2nd compared to 1st quartile residents; RR 1.98, 95%
CI: 1.26-3.13 for 3rd compared to 1st quartile residents). Having an unemployed household
head was significantly associated with MPV risk (RR 2.11, 95% CI: 1.12-4.01).
Conclusion
In rural high altitude communities in Peru, childhood ARI due to RSV or MPV were common
and associated with higher morbidity than ARI due to other viruses or with no viral detec-
tions. The risk factors identified in this study may be considered for interventional studies to
control infections by these viruses among young children from developing countries.
Introduction
Lower respiratory tract infection (LRTI) is the leading global cause of death in children
between one month and five years of age [1–4]. Approximately 70% of LRTI deaths under five
years of age are among children in developing regions [1, 3]. However, the precise reasons for
this disparity in childhood mortality between developed and developing countries are not well
understood.
Viruses are commonly detected in childhood respiratory disease in both developed and
developing countries [4–8]. Among respiratory viruses, respiratory syncytial virus (RSV) [4–6,
9–22] and human metapneumovirus (MPV) [13, 20–23] are the leading causes of LRTI among
children. Although the epidemiology of these viruses has been well characterized in developed
countries [24, 25], fewer data exist about their burden and risk factors for developing countries,
where their disease burden and related-mortality seem to be the highest [1, 3, 11, 26]. The
dearth of information is especially prominent for rural communities where research is typically
difficult to conduct due to unique settings, such as high altitudes, that may also influence dis-
ease burden [27–29].
Most of the current literature on childhood respiratory disease in developing countries
focuses on populations from tropical climates [30], urban areas, or settings where healthcare
access is available and information is gathered during healthcare visits [9, 13, 14, 18, 21–24,
30–33]. In rural communities with limited access to health centers, passive surveillance per-
formed at healthcare centers may not reflect the overall disease burden, severity, or risk factors
in the community [10, 34, 35]. In those settings, active household-based studies conducted
within the community can provide a more comprehensive perspective on disease patterns. Our
study sought to quantify the RSV- and MPV-specific burden of acute respiratory infections
and to identify risk factors for these infections among children from rural communities in the
remote highlands of Peru.
Materials and Methods
The present study was nested within the RESPIRA-PERU study [36], a prospective, household-
based, active surveillance cohort study conducted in the rural highlands of San Marcos,
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Cajamarca, Peru during March 2009 –September 2011. This region is notably high altitude
(1500–4000 meters above sea level) and remote with a population density of 38 persons/km2.
Ethics Statement
Written informed consent was obtained from all participants’ parents or guardians prior to
enrollment. The RESPIRA-PERU project was approved by the IRB of both Vanderbilt Univer-
sity and the Instituto de Investigación Nutricional in Peru.
Study Population
Enrollment criteria have been previously described [37]. Briefly, the study population included
children aged<3 years old whose families planned to remain in the study area for at least a
year after enrollment.
The integrating home-based environmental interventions (IHIP) trial
Before the RESPIRA-PERU study, the IHIP trial, a clustered randomized controlled study, was
conducted in the same study area [38]. The IHIP trial randomized children to improved cook
stoves, solar water disinfection units, and kitchen sinks with running water in order to decrease
the frequency of diarrhea and LRTI. Control families were given a mother-child psychomotor
stimulation intervention. Children who had participated in the IHIP trial for either arm were
eligible to participate in the RESPIRA-PERU study if they met our enrollment selection
criteria.
Household Visits and Data Collection
Data were gathered by local field workers who were trained by study personnel according to
the World Health Organization (WHO) Integrated Management of Childhood Illness (IMCI)
protocol [39–41]. Field workers visited study participants weekly at their homes to obtain
information about any respiratory symptoms during the previous seven days. If one visit was
missed, during the next visit information was recorded for the previous 14 days. If two or more
consecutive visits were missed, data were recorded only for the 14 days prior to the successful
visit.
Definitions of ARI and LRTI
ARI was defined as the presence of reported fever or cough; and LRTI as the presence of at
least one of the following: age-specific tachypnea, audible wheezing, intercostal and subcostal
retractions, nasal flaring, or stridor [40]. To distinguish separate episodes of ARI, at least seven
days without fever or cough were required between episodes. Only children with ARI symp-
toms on the day of the visit or the day prior were further evaluated for signs of LRTI as previ-
ously defined.
Collection and analysis of specimens
When an ARI was reported within the previous seven days including the visit day, field workers
collected a nasal swab, placed it into Remel M4RT viral transport media (Thermo Fisher Scien-
tific Remel Products, Lenexa, KS) and delivered to the local research laboratory in San Marcos
within 8 hours of collection for processing and storage. Samples were subsequently shipped to
Vanderbilt University for testing using real-time RT-PCR targeting the following respiratory
viruses: rhinovirus, adenovirus, parainfluenza (types 1, 2, 3), influenza (A, B, C), RSV and
MPV. [36].
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RSV and MPV Seasons
To assure that our risk factor assessment was restricted to periods at risk for RSV and MPV
infections, risk factor analyses were only performed during seasons when RSV and MPV were
circulating. The beginning of a specific season was defined as the first week of continuous RSV/
MPV activity with one or more test positives in two consecutive weeks. The end of a season
was defined as the last week of two consecutive weeks with at least one infection per week.
Statistical Analysis
Descriptive analysis was conducted and frequencies, means, medians, and proportions were
reported for RSV episodes without MPV co-detection and for MPV episodes without RSV co-
detection. Wilcoxon rank sum tests for continuous data and Chi-squared tests for contingency
tables were used to examine differences in clinical attributes between RSV and MPV episodes
in which only one virus was detected. For comparison purposes, we grouped non-study viruses
as “Other Virus” encompassing rhinovirus, adenovirus, parainfluenza (types 1, 2, 3), or influ-
enza (A, B, C) infections. A separate “No Virus Detected” group included those ARI in which
none of the tested viruses were detected.
Incidence rates were calculated by dividing the number of new ARI’s by person-time of
observation at risk with the rates expressed as ARI incidence per 100 child-years, while
accounting for individual and village clustering to obtain robust standard errors, and 95% CI’s
of ARI incidence rates were reported. Incidence rate comparisons were performed using inci-
dence rate ratios. For the identification of risk factors, we fit virus-specific multivariable mixed
effects Poisson regression models. Factors evaluated simultaneously included age, gender, cal-
endar year, sharing a bed, the number of household members per bedroom, day care atten-
dance, presence of a smoker, maternal education level, dirt flooring, the household head’s
occupation, presence of electricity, water source, disposal services and sewage, altitude, and
IHIP participation status. Multilevel multiple imputation was performed to account for obser-
vations with missing covariate data (<8%) [42]. Analyses were repeated in a complete case sce-
nario (without data imputation). All statistical analyses were performed using Stata 13.1
software (STATACorp College Station, TX).
Results
The RESPIRA-PERU study enrolled 892 children from 810 households in 58 communities in
the San Marcos province. There were 4,475 ARI episodes during a total of 755.1 child-years at
risk (median follow-up of 0.81 child-years per child), with 226 episodes involving RSV and 130
involving MPV. Co-infection with RSV and MPV occurred in only two ARI episodes. 202
(23%) children had at least 1 RSV infection and 127 (14%) children had at least 1 MPV infec-
tion. Of note, in 42% of RSV ARI and 33% of MPV ARI other study viruses were co-detected,
with rhinovirus responsible for 75% of the RSV co-detections and 65% of the MPV co-
detections.
The average age of participants across all infection categories was 15 months. Approxi-
mately half of all participants were female. Most participants had dirt floors in their houses
(>91%), used a solid form (coal or wood) of cooking fuel (>91%), lived with a household
member who worked in agriculture (>76%), and had mothers who did not complete secondary
school (>84%) [36]. These characteristics reflect the rural setting and poverty in which these
participants reside. Additionally, 3 out of 4 participants across all infection categories resided
at altitudes higher than 2314 meters above sea levels. Demographics and characteristics associ-
ated with infections involving RSV, MPV, other viruses, and no viral detections are shown in
Table 1.
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Although the mean age for both infections was similar (16 months), the risk of RSV and
MPV infections differed by age. The incidence of RSV was highest in children under 12 months
of age (34 per 100 child-years, 95% CI: 25–46) and lowest in children from 24–35 months (25,
95% CI: 19–32). In contrast, the highest rate of MPV infection was in children between 6–11
months (27, 95% CI: 19–37) and lowest in children under 6 months of age (12, 95% CI: 14–20).
The RSV incidence rates were significantly higher than MPV rates for each age group except
among children 6–11 months of age (p = 0.14) (Table 2).
Table 3 describes the clinical manifestations of RSV and MPV infections. The reported days
of fever among RSV and MPV infections were each longer than duration of fever in infections
where no virus was detected. RSV ARI was more likely to present as an LRTI and to result in
an ARI clinic visit or hospitalization compared with ARI due to other viral infections and ARI
in which no virus was detected. Similarly, MPV infections were more likely to present with
Table 1. Demographics and characteristics associated with ARI episodes by virus type.
Characteristic RSV (n = 224) MPV (n = 128) Other Viral (n = 2294) No Virus Detected (n = 1309)
Age in months, mean (95% CI) 15.4 (14.1–16.7) 15.9 (14.2–17.6) 15.9 (15.5–16.3) 14.1 (13.6–14.7)
Female 49.5 (44–57) 53.9 (47.4–55) 47.8 (46.1–59.2) 47.3 (45–50.4)
Year
2009 10.7 (6.7–14.8) 9.4 (4.3–14.4) 19.7 (18.1–21.3) 26.4 (24–28.8)
2010 41.5 (35–48) 27.3 (19.6–35.1) 49.8 (47.7–51.8) 48.4 (45.7–51.1)
2011 47.8 (41.2–54.3) 63.4 (54.9–71.7) 30.5 (28.6–32.4) 25.1 (22.8–27.5)
Shared a bed 98.2 (96.4–99.9) 99.2 (97.7–1.01) 97.6 (96.9–98.2) 96.9 (96–97.9)
Attended day care 7.2 (3.8–10.6) 5.5 (1.5–9.4) 7.4 (6.3–8.5) 6.3 (5–7.6)
People per household, median (IQR) 5 (4–7) 5 (4–6) 5 (4–6) 5 (4–6)
Children <5y per household, median (IQR) 1 (1–2) 1 (1–2) 1 (1–2) 1 (1–2)
Number of bedrooms, median (IQR) 2 (1–2) 1 (1–2) 1 (1–2) 1 (1–2)
Electricity in home 40.2 (33.7–46.6) 48.4 (39.7–57.1) 40.7 (38.7–42.7) 43.2 (40.5–45.9)
Water from pipeline or well 80.4 (75.1–85.6) 88.3 (82.7–93.9) 85.3 (83.8–86.7) 86.6 (84.8–88.5)
Municipal sewer or septic tank 21 (15.6–26.3) 25 (17.5–32.5) 20 (18.4–21.7) 19.1 (17–21.3)
Dirt floor 93.8 (90.6–96.9) 85.9 (80–92) 91.2 (90–92.4) 89.9 (88.3–91.5)
Cooking fuel
Gas 4.0 (1.5–6.6) 3.1 (0.1–6.1) 3.7 (2.9–4.4) 4.8 (3.7–6.0)
Wood 94.6 (91.7–97.6) 96.1 (92.7–99.5) 95.2 (94.3–96.1) 93.4 (92–94.7)
Head of household in agriculture 77.7 (72.2–83.1) 68 (60–76.1) 76.7 (75–78.5) 76.1 (73.7–78.4)
Mother did not complete secondary school 87.7 (83.4–92.1) 85.8 (79.7–91.9) 88.9 (87.6–90.2) 87.1 (85.3–89)
Altitude quartile (m)
1976–2314 17.4 (12.4–22.4) 26.6 (18.9–34.2) 25.4 (23.6–27.2) 26.4 (24–28.7)
2315–2626 27.7 (21.8–33.6) 25.8 (18.2–33.4) 24.5 (22.8–26.3) 24.5 (22.2–26.9)
2628–2865 27.7 (21.8–33.6) 19.5 (12.6–26.4) 24.9 (23.2–26.7) 26.3 (23.9–28.7)
2866–3803 27.2 (21.4–33.1) 28.1 (20.3–35.9) 25.2 (23.4–26.9) 22.8 (20.6–25.1)
IHIP trial status
Non-participant 85.7 (81.1–90.3) 88.3 (82.7–93.9) 81.2 (79.6–82.8) 81.5 (79.4–83.6)
Participant, control arm 6.3 (3.1–9.4) 7 (2.6–11.5) 11.2 (9.9–12.4) 9.4 (7.8–10.9)
Participant, intervention arm 8 (4.5–11.6) 4.7 (1–8.4) 7.6 (6.5–8.7) 9.1 (7.5–10.6)
Data are displayed as percentages (95% CI) unless otherwise noted.
RSV and MPV values were calculated using infections either with RSV + no MPV or MPV + no RSV. Therefore, this data do not necessarily reflect
isolated infections. The two RSV+MPV episodes were not included for this table. 42% of RSV ARI and 33% of MPV ARI were co-detected with other
study viruses. “Other Viral” ARI included rhinovirus, adenovirus, parainfluenza (types 1, 2, 3), and influenza (A, B, C).
doi:10.1371/journal.pone.0130233.t001
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tachypnea and result in an ARI clinic visit or hospitalization when compared to other viral ARI
and ARI with no virus detected. RSV and MPV accounted for approximately 30.4% and 13% of
virus-positive hospitalizations where one virus was detected. The next most common virus–
rhinovirus–was detected in approximately 21.8% of hospitalizations. Approximately 10.7%
and 6.9% of RSV and MPV ARI were associated with LRTIs, yielding incidence rates of 1.8 and
Table 2. RSV andMPV incidence rates per 100 child-years stratified by age.
Viral Infection Type Total Cases Total Child-years Incidence rate per 100 child-years (95% CI)
RSV
All ages (months) 226 755 30 (26–34)
0–5 44 128 34 (25–46)
6–11 47 139 34 (25–45)
12–23 77 253 31 (24–38)
24–35 58 235 25 (19–32)
MPV
All ages 130 755 17 (14–20)
0–5 16 128 12 (8–20)
6–11 37 139 27 (19–37)
12–23 39 253 15 (11–21)
24–35 38 235 16 (12–22)
doi:10.1371/journal.pone.0130233.t002
Table 3. Clinical attributes by viral infection type.
Viral
Infection
Age in
months,
mean
Symptom
Duration
(days)
Fever
(days)
Cough
(days)
Rhinorrhea
(days)
Audible
Wheezingθ
(%)
Tachypneaθ
(%)
Any
sign of
LRTIθ
(%)
Clinic
visit for
ARI (%)
Hospitalized
(%)
RSV*
(n = 131)
16.1
(14.3–
17.9)
8 (5–10) 2 (1–3) 7 (5–10) 6 (4–8) 1.5 (0–3.6) 9.2 (4.2–14.1) 10.7
(5.4–16)
41
(32.8–
50)
5.3 (1.5–9.2)
RSV**
(n = 224)
15.4
(14.1–
16.7)
7 (5–11) 2 (0–3) 6 (4–10) 6 (3–9) 1.3 (0–2.8) 9.4 (5.6–13.2) 10.7
(6.7–
14.8)
40.6
(23.2–
47.1)
4.0 (1.4–6.6)
MPV*
(n = 87)
15.9
(13.8–
18.1)
7 (5–10) 2 (1–4) 6 (4–9) 6 (3–9) 1.1 (0–3.4) 6.9 (1.6–12.2) 6.9 (1.6–
12.2)
38
(27.7–
48.1)
3.5 (0–7.3)
MPV**
(n = 128)
15.9
(14.2–
17.6)
7 (4–9) 2 (1–4) 6 (4–9) 6 (3–8) 0.8 (0–2.3) 7.8 (3.2–12.5) 7.8 (3.2–
12.5)
35
(26.9–
43.4)
2.3 (0–5)
Other
Virus*
(n = 1885)
15.5
(15.1–16)
5 (3–9) 1 (0–2) 5 (2–8) 4 (2–7) 0.3 (0.1–0.6)† 2.4 (1.7–
3.1)†=l
3.7 (2.8–
4.5)†
23 (21–
25)†=l
0.7 (0.3–
1.1)†=l
No Virus
Detected
14.1
(13.6–
14.7)
4 (2–8)=l 2 (1–
3)†=l
3 (0–6) 2 (0–5) 0.5 (0.1–0.9) 1.2 (0.6–
1.8)†=l
2.4 (1.6–
3.3)†=l
24
(21.8–
26.4)†=l
0.6 (0.2–
1.0)†=l
Data represent median values (IQR) and proportions (95% CI).
Values that were significantly different (p<0.05) when compared to RSV* (†) and MPV* (=l).
*These values for RSV, MPV, and other virus infections include infections with only 1 virus detected.
**These values include co-infections.
θWheezing, tachypnea, and any LRTI symptoms were calculated among all children with ARI regardless of whether or not an exam was performed for the
given symptom. Tachypnea was defined separately for specific age groups.
doi:10.1371/journal.pone.0130233.t003
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0.8 LRTIs per 100 child-years, respectively. The clinical manifestations of the ARI with a single
virus were not significantly different from ARI that included other viral co-detections.
The risk factors for RSV and MPV infections also differed. In multivariable analyses youn-
ger age, the presence of a smoker, and living at higher altitudes (specifically 2315–2865 meters
above sea level compared to 1976–2314 meters) were identified as independent risk factors for
RSV infection. The only significant risk factor for MPV in multivariable analysis was the occu-
pation of the household head, which was not so for RSV. Specifically, higher MPV risk was
associated with unemployed household heads when compared with household heads with
some type of employment (Table 4). Separate analyses without data imputation yielded results
similar to those from the main analyses (S1 Table).
Discussion
In our study, ARI due to RSV and MPV were very common among young children living in
rural communities of the Peruvian Andes. RSV and MPV ARI were also more likely to exhibit
indicators of severe disease such as tachypnea, clinic visits, and hospitalizations than ARI from
other viral causes or when no viruses were detected. Risk factors for RSV detection were youn-
ger age, presence of an indoor smoker, and living at high altitudes. Conversely, age, smoking,
and altitude were not associated with MPV infection risk. The only significant risk factor for
MPV ARI was the head of household’s occupation, with higher risk associated with
unemployment.
Our RSV ARI incidence rate of 30 events per 100 child-years is similar to that of prospec-
tive, household-based studies conducted in two low resource settings at lower altitude (about
36 events per 100 child-years) [17, 30]. To our knowledge, the only other household-based
study that has assessed the burden of MPV infections in young children found an incidence
rate of 7 per 100 child-years among the urban poor of Bangladesh [21], which was much lower
than our observed MPV rate of 17 per 100 child-years. Of note, that study in Bangladesh
required one major or multiple minor criteria for physician referral where the final ARI diag-
nosis was made, which may explain this difference in incidence rates. In previous studies per-
formed by our group among young U.S. children, the rates of outpatient clinic visits for RSV
and MPV infections in infants were much higher than the rates in this household-based study
[24, 25]. This may largely be a reflection of greater access to outpatient care.
The age distribution of RSV and MPV appeared to have distinct patterns. RSV incidence
rates were highest in children less than 12 months whereas MPV rates were highest only in the
6–11 month age range. Consistent with our results, several studies conducted at health facilities
in developed countries have reported that MPV tend to affect older infants whereas RSV affects
both younger and older infants [13, 24]. For example, rates of RSV among outpatient children
<6 months and 6–11 months were both high and similar to each other in a study conducted by
our colleagues among US children [25]. In another study by our group, rates of MPV were
higher for those 6–11 months than less than 6 months in that same population of US children
[24]. Similar RSV and MPV studies conducted in developing regions only report LRTI rates,
but demonstrate similar age patterns, with RSV LRTI incidence rates highest among infants
0–6 months and MPV LRTI rates highest in 6–12 month olds [21, 43]. Although these studies
have been conducted in different settings and use different methodologies, it appears that the
age distribution of RSV and MPV ARI may be similar between studies conducted in developing
and developed regions.
There was substantial clinical overlap between RSV and MPV ARI regarding duration of
different symptoms. This is not surprising since both viruses belong to the same viral subfam-
ily, tend to circulate between December and April in the Northern hemisphere in developed
Incidence and Risk of Respiratory Syncytial Virus and Metapnuemovirus
PLOS ONE | DOI:10.1371/journal.pone.0130233 June 24, 2015 7 / 13
Table 4. Risk factors for specific viral infections.
RSV (n = 184) MPV (n = 102)
Univariate Multivariable Univariate Multivariable
Characteristic Rate Ratio (RR)
(CI)
P
value
RR (CI) P
value
RR (CI) P
value
RR (CI) P
value
Age (months) 0.98 (0.97–1.00)
†
0.01 0.98 (0.96–
0.99) †
0.01 0.99 (0.97–
1.01)
0.24 1.00 (0.98–
1.03)
0.77
Female 0.92 (0.70–1.21) 0.56 0.95 (0.73–
1.25)
0.73 1.06 (0.74–
1.52)
0.74 1.12 (0.79–
1.60)
0.53
Year
2009 Reference
2010 0.85 (0.48–1.52) 0.58 0.83 (0.44–
1.56)
0.57 0.91 (0.38–
2.18)
0.83 0.64 (0.21–
1.91)
0.43
2011 1.00 (0.57–1.77) 0.99 1.05 (0.53–
2.09)
0.90 1.41 (0.63–
3.15)
0.41 0.78 (0.24–
2.48)
0.67
Shares a bed 2.72 (0.73–10.2) 0.14 2.53 (0.66–
9.70)
0.18 2.73 (0.41–
18.2)
0.30 3.23 (0.51–
20.5)
0.21
Persons per bedroom 0.99 (0.95–1.04) 0.79 0.99 (0.93–
1.04)
0.61 0.96 (0.88–
1.04)
0.31 0.97 (0.90–
1.05)
0.49
Attended day care 1.01 (0.62–1.64) 0.97 1.33 (0.80–
2.21)
0.28 0.70 (0.31–
1.60)
0.40 0.78 (0.35–
1.76)
0.55
Smoker in the house 1.62 (1.13–2.33)
†
0.01 1.63 (1.12–
2.38) †
0.01 1.45 (0.88–
2.37)
0.14 1.42 (0.84–
2.38)
0.19
Dirt floor 1.50 (0.88–2.54) 0.14 1.51 (0.87–
2.61)
0.14 0.67 (0.40–
1.11)
0.12 0.75 (0.44–
1.29)
0.30
Electricity in home 0.86 (0.65–1.14) 0.30 1.05 (0.78–
1.42)
0.73 1.22 (0.85–
1.75)
0.27 1.04 (0.69–
1.58)
0.84
Water from pipeline or well 0.78 (0.55–1.11) 0.17 0.81 (0.55–
1.19)
0.28 1.72 (0.88–
3.37)
0.11 1.71 (0.87–
3.34)
0.12
Municipal sewer or septic tank 0.92 (0.66–1.28) 0.61 1.02 (0.72–
1.45)
0.90 1.05 (0.68–
1.63)
0.87 0.87 (0.53–
1.42)
0.57
Occupation of household head
Non-agricultural Reference
Agricultural 1.03 (0.72–1.48) 0.86 0.80 (0.55–
1.63)
0.24 0.71 (0.46–
1.08)
0.11 0.68 (0.42–
1.08)
0.10
Unemployed/other 0.70 (0.28–1.76) 0.45 0.65 (0.24–
1.76)
0.40 2.19 (1.19–
4.03) †
0.01 2.11 (1.12–
4.01) †
0.02
Mother did not complete secondary
school
1.32 (0.85–2.05) 0.22 1.13 (0.74–
1.74)
0.58 0.97 (0.59–
1.59)
0.90 1.25 (0.74–
2.11)
0.40
Altitude quartile (m)
1976–2314 Reference
2315–2626 2.06 (1.34–3.17)
†
<0.01 1.93 (1.25–
3.00) †
<0.01 1.17 (0.74–
1.84)
0.51 1.29 (0.83–
2.01)
0.26
2628–2865 1.82 (1.18–2.82)
†
0.01 1.98 (1.26–
3.13) †
<0.01 0.62 (0.36–
1.09)
0.10 0.83 (0.46–
1.50)
0.54
2866–3803 1.75 (1.10–2.76)
†
0.02 1.67 (0.99–
2.79)
0.05 0.91 (0.55–
1.50)
0.70 1.21 (0.70–
2.09)
0.49
IHIP trial status
Non-participant Reference
Participant, control 0.56 (0.30–1.02) 0.06 0.78 (0.39–
1.56)
0.48 0.70 (0.35–
1.41)
0.32 0.68 (0.25–
1.83)
0.44
(Continued)
Incidence and Risk of Respiratory Syncytial Virus and Metapnuemovirus
PLOS ONE | DOI:10.1371/journal.pone.0130233 June 24, 2015 8 / 13
countries [23, 24, 32], and both are associated with bronchiolitis [4, 13, 22, 23]. Furthermore,
these viruses frequently co-circulate during respiratory seasons in our study region as well [36].
These two viruses have similar patterns of severity in our study. The overlap of certain clinical
manifestations such as audible wheezing and tachypnea seen with bronchiolitis highlights the
frequent involvement of the lower respiratory tract with these two viruses. Other studies in
developing regions often cite RSV and MPV as the most common causes of LRTI compared to
other common childhood respiratory pathogens [10, 20–23]. Of note, some of those studies
defined LRTI as hospitalization or presence of tachypnea alone. Therefore, our results seem
consistent with those studies since RSV and MPV did have significantly stronger associations
with hospitalization compared to non-RSV and non-MPV infections. Our percentages of
virus-positive hospitalizations attributable to RSV and MPV were also consistent with similar
studies. LRTI among hospitalized children in Brazil were associated with RSV and MPV in
86% of all the virus-positive cases, while the other viruses comprised 14% of episodes [20].
Other studies by our group in US health facilities found that 20% and 6% of children under 5
years who were hospitalized for ARI were due to RSV and MPV, respectively [24, 25]. Overall,
it appears that RSV and MPV ARI are significantly associated with indicators of more severe
disease in both developed and developing countries.
Previous studies in low-resource settings have found that crowding is a significant risk fac-
tor for severe childhood RSV infection [14, 30, 33, 44, 45]. In our study, RSV and MPV ARI
were not significantly associated with crowding. This finding should be interpreted with cau-
tion. First, crowding likely presents more risk indoors than outdoors and our study is unable to
differentiate between times spent in these two settings. Additionally, the number of persons
per household in our study (median of 5) was low compared to similar studies that did detect
an association with crowding. For example, a study conducted in rural Alaska [33], where it is
common to have 6 people per household [44], found a significant relationship between crowd-
ing and RSV hospitalizations of children>6 months only when the number of people in the
household was at least eight. Similarly, a study in Gambia [14] used a threshold of 10 house-
hold members to define crowding. It should be noted that these studies assessed for hospitaliza-
tion as a primary outcome, whereas we focused on all respiratory disease episodes. The risk
factor of crowding may be limited to RSV hospitalization risk. Consistent with this observation
is the finding from a Kenyan study [30] that increasing numbers of children in the household
were not associated with RSV ARI, but was associated with LRTI when the number of children
exceeded ten. Unfortunately, evaluation of the relationship between hospitalizations and
crowding was unable to be performed in our study due to the low number of hospitalizations
from these rural isolated communities.
A number of studies conducted in developed [13, 18] and developing countries [31] have
reported that having a smoker in the house increases the risk of RSV infection. Okiro et al [30]
Table 4. (Continued)
RSV (n = 184) MPV (n = 102)
Univariate Multivariable Univariate Multivariable
Participant, intervention 0.84 (0.53–1.32) 0.45 1.09 (0.60–
1.99)
0.78 0.39 (0.15–
1.04)
0.06 0.42 (0.13–
1.36)
0.15
Values that were significantly different (p<0.05) when compared to reference values are indicated by the symbol †. Numbers of RSV and MPV infections
are smaller than Table 2 because analysis was restricted to infections occurring during the RSV or MPV season among children who were observed and
at risk during each season.
doi:10.1371/journal.pone.0130233.t004
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found that RSV ARI risk increased significantly if at least 2 smokers were present in the house-
hold. Other studies have specifically demonstrated an association between maternal smoking
and LRTI in the first year of life [46, 47]. In our study, we observed a significant relationship
between indoor smoking and RSV infection but the association with MPV infection did not
reach statistical significance. Although the point estimates were similar to associations previ-
ously reported, the prevalence of smoking was relatively low in the study population and the
precision of our MPV estimates was limited. Interestingly, we also noted that although the risk
of RSV infections was not strongly associated with the household head’s occupation, we
observed a significant association between a MPV infection rate and household head’s occupa-
tion. This observation is intriguing but requires subsequent assessment in other settings.
A previous article on risk factors for RSV ARI reported that children living above 2500
meters were 33% more likely to be hospitalized for RSV compared to those living below 2500
meters [29]. Similarly, a 2008 WHO report mentions “high altitude (cold air)” as a possible
risk factor for childhood community-acquired pneumonia [28]. This is congruent with our
results, which show that the risk of RSV ARI increases with increasing altitude beyond 2300
meters. Besides the temperature differences, higher altitudes generally have lower oxygen satu-
ration levels, can induce pulmonary vasoconstriction secondary to hypoxia, and can cause
impaired nasal mucociliary transport, all of which may affect susceptibility to respiratory infec-
tion [27, 48]. In our study, however MPV infection rates appear to be less affected by altitude,
which may suggest unique aspects of MPV infection, such as the effects of temperature on viral
replication, transmission, or virulence. To our knowledge, this is one of few studies that have
specifically explored the association of MPV infection with high altitude in the literature.
Our findings must be interpreted in light of some limitations. Our risk factor analyses
required restrictions such as stratifying the primary participant group that likely limited our
sample size and statistical power to detect some associations. Second, other relevant variables
such as time-varying nutritional or immunological status of the study children were not gath-
ered as part of the study, and thus remained unaccounted for in our analyses. Third, samples
were only gathered during ARI episodes, though virus could have been present during asymp-
tomatic periods. Nevertheless, previous studies using molecular detection techniques have con-
sistently shown that RSV and MPV were rarely detectable in asymptomatic young children
[32, 49, 50], which should mitigate that concern. Fourth, although viruses account for a major-
ity of respiratory disease in children, bacteria also play an important role in severe disease. The
bacterial etiology of study ARIs was not assessed in this study. In a number of RSV and MPV
infections we also detected other viruses, especially rhinovirus. Although these co-infections
might impact disease severity, the majority of RSV and MPV infections in our study did not
have viral co-detections and we did not find significant differences in clinical manifestations or
healthcare use between those with and without co-detections. Finally, even though our study
was conducted in the rural, highland communities of the Andes, these results may not repre-
sent other populations who also live in high altitudes. Nevertheless, these populations are typi-
cally excluded from traditional research, and information on the epidemiology of viral
infections in this setting is lacking.
In conclusion, RSV and MPV ARI were very common among young Andean children.
Both viruses shared many clinical symptoms between each other as well as with other viruses.
RSV and MPV ARI notably presented with more indicators of severe disease than infections
due to other viral causes. The risk factors identified in this study may be considered for further
interventions to control infections by these viruses among young children from developing
countries.
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Supporting Information
S1 Table. Risk factors for specific viral infections without imputation. Values that were sig-
nificantly different (p<0.05) when compared to reference values are indicated by the symbol †.
Numbers of RSV and MPV infections are smaller than Table 3 because analysis was restricted
to infections occurring during the RSV or MPV season among children who were observed
and at risk during each season.
(DOCX)
Acknowledgments
On behalf of the study of Respiratory Infections in Andean Peruvian children (RESPIRA-
PERU): Vanderbilt University, Marie R. Griffin, John V. Williams, Kathryn M. Edwards, Mon-
ika Johnson, Philip J. Budge, Yuwei Zhu, Carlos G. Grijalva; Emory University, Jorge E. Vidal,
Keith P. Klugman; Swiss Tropical and Public Health Institute, Stella Hartinger, MSc, PhD;
Instituto de Investigacion Nutricional, Hector Verastegui, Ana I. Gil, Claudio F. Lanata. We
especially want to thank the communities and families of San Marcos, Cajamarca Peru for their
participation and cooperation in this study. We sincerely appreciate the approval and contin-
ued support of the Cajamarca Health Region authorities, and we are indebted to the local
health workers who persevered in harsh environments over two years to conduct this study to
work for better health of children in their communities.
Author Contributions
Conceived and designed the experiments: JWMG KEMJ SH HV AG CL CG. Performed the
experiments: MG KE SH CG. Analyzed the data: AW PB YZ CG. Contributed reagents/materi-
als/analysis tools: JW HV AG CL. Wrote the paper: AW PB JWMG KE YZ HV CL CG.
References
1. Global Burden of Disease (GBD) Compare. In: Compare G, editor. Institute for Health Metrics and Eval-
uation (IHME): The Lancet; 2010.
2. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of
child mortality: an updated systematic analysis for 2010 with time trends since 2000. The Lancet. 2012;
379(9832):2151–61.
3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality
from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Bur-
den of Disease Study 2010. The Lancet. 2012; 380(9859):2095–128. http://dx.doi.org/10.1016/S0140-
6736(12)61728-0.
4. Simoes EC, T. Chow J. et al. Acute Respiratory Infections in Children. In: Jamison DB, JG. Measham
AR. et al., editor. Disease Control Priorities in Developing Countries. 2nd edition ed. Washington (DC):
World Bank; 2006.
5. Claesson BA, Trollfors B, Brolin I, Granstrom M, Henrichsen J, Jodal U, et al. Etiology of community-
acquired pneumonia in children based on antibody responses to bacterial and viral antigens. The Pedi-
atric Infectious Disease Journal. 1989; 8(12):856–61. PMID: 2516622
6. Juven T, Mertsola J, Waris M, Leinonen M, Meurman O, Roivainen M, et al. Etiology of community-
acquired pneumonia in 254 hospitalized children. The Pediatric Infectious Disease Journal. 2000; 19
(4):293–8. PMID: 10783017
7. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, et al. Epidemiology and Clinical Char-
acteristics of Community-Acquired Pneumonia in Hospitalized Children. Pediatrics. 2004; 113(4):701–
7. PMID: 15060215
8. Wubbel L, Muniz L, Ahmed A, Trujillo M, Carubelli C, McCoig C, et al. Etiology and treatment of commu-
nity-acquired pneumonia in ambulatory children. The Pediatric Infectious Disease Journal. 1999; 18
(2):98–104. PMID: 10048679
Incidence and Risk of Respiratory Syncytial Virus and Metapnuemovirus
PLOS ONE | DOI:10.1371/journal.pone.0130233 June 24, 2015 11 / 13
9. Law BJ, Carbonell-Estrany X, Simoes EAF. An update on respiratory syncytial virus epidemiology: a
developed country perspective. Respiratory Medicine. 2002; 96, Supplement 2(0):S1–S7. http://dx.doi.
org/10.1053/rmed.2002.1294.
10. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower
respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-
analysis. The Lancet. 2010;(1474-547X (Electronic)).
11. Peltola V, Ruuskanen O. Respiratory Viral Infections in Developing Countries: Common, Severe, and
Unrecognized. Clinical Infectious Diseases. 2008; 46(1):58–60. doi: 10.1086/524020 PMID: 18171214
12. Kwofie TB, Anane YA, Nkrumah B, Annan A, Nguah SB, Owusu M. Respiratory viruses in children hos-
pitalized for acute lower respiratory tract infection in Ghana. Virology Journal. 2012;(1743-422X
(Electronic)).
13. Papenburg J, Hamelin M-È, Ouhoummane N, Carbonneau J, Ouakki M, Raymond F, et al. Comparison
of Risk Factors for Human Metapneumovirus and Respiratory Syncytial Virus Disease Severity in
Young Children. Journal of Infectious Diseases. 2012; 206(2):178–89. doi: 10.1093/infdis/jis333 PMID:
22551815
14. Weber MW, Milligan P, Hilton S, Lahai G, Whittle H, Mulholland EK, et al. Risk factors for severe respi-
ratory syncytial virus infection leading to hospital admission in children in the Western Region of The
Gambia. International Journal of Epidemiology. 1999; 28(1):157–62. doi: 10.1093/ije/28.1.157 PMID:
10195682
15. Infection and Incidence: Respiratory Syncytial Virus Infection: Centers for Disease Control and Preven-
tion; 2010 [April 19, 2014].
16. Munywoki PK, Koech DC, Agoti CN, Lewa C, Cane PA, Medley GF, et al. The Source Of Respiratory
Syncytial Virus Infection In Infants: A Household Cohort Study In Rural Kenya. Journal of Infectious Dis-
eases. 2013. 10.1093/infdis/jit828.
17. Nokes DJ, Okiro EA, NgamaM, Ochola R, White LJ, Scott PD, et al. Respiratory syncytial virus infec-
tion and disease in infants and young children observed from birth in Kilifi District, Kenya. Clinical Infec-
tious Diseases. 2008;(1537–6591 (Electronic)).
18. von LinstowML, Hogh M, Nordbo SA, Eugen-Olsen J, Koch A, Hogh B. A community study of clinical
traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the
first year of life. European Journal of Pediatrics. 2008;(1432–1076 (Electronic)).
19. Hortal M, Mogdasy C, Russi JC, Deleon C, Suarez A. Microbial agents associated with pneumonia in
children from Uruguay. Review of Infectious Diseases. 1990;(0162–0886 (Print)).
20. da Silva ER, Pitrez MC, Arruda E, Mattiello R, Sarria EE, de Paula FE, et al. Severe lower respiratory
tract infection in infants and toddlers from a non-affluent population: viral etiology and co-detection as
risk factors. BMC Infectious Diseases. 2013;(1471–2334 (Electronic)).
21. Homaira N LS, Petri WA, Vainionpaa R, RahmanM, et al. Incidence of Respiratory Virus-Associated
Pneumonia in Urban Poor Young Children of Dhaka, Bangladesh, 2009–2011. PLoS ONE 2012; 7(2).
doi: 10.1371/journal.pone.0032056
22. Singleton RJ, Bulkow LR, Miernyk K, DeByle C, Pruitt L, Hummel KB, et al. Viral respiratory infections
in hospitalized and community control children in Alaska. Journal of Medical Virology. 2010; 82
(7):1282–90. doi: 10.1002/jmv.21790 PMID: 20513097
23. Foulongne V, Guyon G, Rodiere M, Segondy M. Human metapneumovirus infection in young children
hospitalized with respiratory tract disease. Pediatric Infectious Disease Journal. 2007;(0891–3668
(Print)).
24. Edwards KM, Zhu Y, Griffin MR,Weinberg GA, Hall CB, Szilagyi PG, et al. Burden of humanmetapneu-
movirus infection in young children. New England Journal of Medicine. (1533–4406 (Electronic)).
25. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The Burden of Respira-
tory Syncytial Virus Infection in Young Children. New England Journal of Medicine. 2009; 360(6):588–
98. doi: 10.1056/NEJMoa0804877 PMID: 19196675.
26. Rudan I, Lawn J, Cousens S, Rowe AK, Boschi-Pinto C, Tomakovi L, et al. Gaps in policy-relevant
information on burden of disease in children: a systematic review. The Lancet. 2005; 365(9476):2031–
40.
27. Barry P, Mason N, O'Callaghan C. Nasal mucociliary transport is impaired at altitude. European Respi-
ratory Journal. 1997; 10(1):35–7. PMID: 9032488
28. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood
pneumonia. Bulletin of the World Health Organization. 2008;(1564–0604 (Electronic)).
29. Sommer C, Resch B, Simoes EA. Open Microbiology Journal. 2011;(1874–2858 (Electronic)). D—
NLM: PMC3258650 OTO—NOTNLM.
Incidence and Risk of Respiratory Syncytial Virus and Metapnuemovirus
PLOS ONE | DOI:10.1371/journal.pone.0130233 June 24, 2015 12 / 13
30. Okiro EA, NgamaM, Bett A, Cane PA, Medley GF, James Nokes D. Factors associated with increased
risk of progression to respiratory syncytial virus-associated pneumonia in young Kenyan children. Trop-
ical Medicine & International Health. 2008; 13(7):914–26. doi: 10.1111/j.1365-3156.2008.02092.x
31. Al-Sonboli N HC, Al-Aghbari N, Al-Ansi A, Ashoor O, Cuevas LE. Human metapneumovirus and respi-
ratory syncytial virus disease in children, Yemen. Emerging Infectious Diseases. 2006. doi: 10.3201/
eid1209.060207
32. Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, et al. Human
Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children.
New England Journal of Medicine. 2004; 350(5):443–50. doi: 10.1056/NEJMoa025472 PMID:
14749452.
33. Bulkow LR, Singleton RJ, Karron RA, Harrison LH. Risk factors for severe respiratory syncytial virus
infection among Alaska native children. Pediatrics. 2002;(1098–4275 (Electronic)).
34. Mulholland K. Global burden of acute respiratory infections in children: implications for interventions.
Pediatric Pulmonology. 2003;(8755–6863 (Print)).
35. Smith KR, McCracken JP, Weber MW, Hubbard A, Jenny A, Thompson LM, et al. Effect of reduction in
household air pollution on childhood pneumonia in Guatemala (RESPIRE): a randomised controlled
trial. The Lancet. 2011; 378(9804):1717–26.
36. Budge PJ, Griffin MR, Edwards KM, Williams JV, Verastegui HA, Hartinger SM, et al. A Household-
based Study of Acute Viral Respiratory Illnesses in Andean Children. The Pediatric Infectious Disease
Journal. 2014.
37. Grijalva CG, Griffin MR, Edwards KM,Williams JV, Gil AL, Verastegui HA, et al. The Study of Respira-
tory Pathogens in Andean Children. International Journal of Epidemiology. 2013;(1464–3685
(Electronic)).
38. Hartinger SM, Lanata CF, Hattendorf J, Gil AL, Verastegui HA, Ochoa T, et al. A community rando-
mised controlled trial evaluating a home-based environmental intervention package of improved
stoves, solar water disinfection and kitchen sinks in rural Peru: rationale, trial design and baseline find-
ings. Contemporary Clinical Trials. 2011;(1559–2030 (Electronic)).
39. Integrated management of childhood illness: conclusions. WHODivision of Child Health and Develop-
ment. 1997;(0042–9686 (Print)).
40. Gove S. Integrated management of childhood illness by outpatient health workers: technical basis and
overview. TheWHOWorking Group on Guidelines for Integrated Management of the Sick Child. Bulle-
tin of theWorld Health Organization. 1997;(0042–9686 (Print)).
41. Lambrechts T, Bryce J, Orinda V. Integrated management of childhood illness: a summary of first expe-
riences. Bulletin of the World Health Organization. 1999;(0042–9686 (Print)).
42. Carpenter JR, Goldstein H, Kenward MG. REALCOM-IMPUTE Software for Multilevel Multiple Imputa-
tion with Mixed Response Types. Journal of Statistical Software. 2011; 45(5).
43. Nokes DJ, Okiro EA, NgamaM, White LJ, Ochola R, Scott PD, et al. Respiratory Syncytial Virus Epide-
miology in a Birth Cohort from Kilifi District, Kenya: Infection during the First Year of Life. Journal of
Infectious Diseases. 2004; 190(10):1828–32. doi: 10.1086/425040 PMID: 15499540
44. Colosia AD, Masaquel A, Hall CB, Barrett AM, Mahadevia PJ, Yogev R. Residential crowding and
severe respiratory syncytial virus disease among infants and young children: a systematic literature
review. BMC Infectious Diseases. (1471–2334 (Electronic)).
45. Simoes EAF. Environmental and demographic risk factors for respiratory syncytial virus lower respira-
tory tract disease. The Journal of Pediatrics. 2003; 143(5):118–26.
46. Duff AL, Pomeranz ES, Gelber LE, Price GW, Farris H, Hayden FG, et al. Risk factors for acute wheez-
ing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics.
1993;(0031–4005 (Print)).
47. McConnochie KM, Roghmann KJ. Parental smoking, presence of older siblings, and family history of
asthma increase risk of bronchiolitis. American Journal of Diseases of Children. 1986;(0002-922X (Print)).
48. Niermeyer S, Shaffer EM, Thilo E, Corbin C, Moore LG. Arterial oxygenation and pulmonary arterial
pressure in healthy neonates and infants at high altitude. The Journal of Pediatrics. 1993; 123(5):767–
72. PMID: 8229488
49. Jansen RR, Wieringa J, Koekkoek SM, Visser CE, Pajkrt D, Molenkamp R, et al. Frequent Detection of
Respiratory Viruses without Symptoms: Toward Defining Clinically Relevant Cutoff Values. Journal of
Clinical Microbiology. 2011; 49(7):2631–6. doi: 10.1128/jcm.02094-10 PMID: 21543571
50. van der Zalm MM, van Ewijk BE, Wilbrink B, Uiterwaal CSPM, Wolfs TFW, van der Ent CK. Respiratory
Pathogens in Children with and without Respiratory Symptoms. The Journal of Pediatrics. 2009; 154
(3):396–400.e1. http://dx.doi.org/10.1016/j.jpeds.2008.08.036. doi: 10.1016/j.jpeds.2008.08.036
PMID: 18823911
Incidence and Risk of Respiratory Syncytial Virus and Metapnuemovirus
PLOS ONE | DOI:10.1371/journal.pone.0130233 June 24, 2015 13 / 13
